Related Experiment Video
Updated: May 30, 2026

Generating Acute and Chronic Experimental Models of Motor Tic Expression in Rats
Published on: May 27, 2021
Memantine and catatonia: a case report and literature review
Demian F Obregon1, Regina M Velasco, Timothy P Wuerz
1University of South Florida Depart ment of Psychiatry and Neurosciences, Tampa, FL, USA.
Abstract:
Catatonia is a movement disorder with various possible etiologies. The majority of cases are associated with an underlying mood or psychotic disorder, while others are caused by medical conditions. Currently, benzodiazepines are the first-line psychopharmacologic agents in the treatment of catatonia. However, several cases have been reported in which treatment with memantine proved to be effective. We present the case of a 92-year-old female with major depressive disorder and associated catatonic symptoms. In this case, the patient's symptoms remitted quickly after the initiation of memantine. We review the possible causes of catatonia and pharmacologic treatments for the condition and highlight the possible benefits of N-methylD-aspartic acid receptor antagonists such as memantine in the treatment of catatonia.
Related Concept Videos
Mania and Antimanic Drugs: Overview
Alterations in Muscle Tone ll
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Alterations in Muscle Tone lll
Drug Therapy
Antianxiety Medications
Long-term Depression
Calcium Ion Concentration Mechanism
If over time, all...
